Strategic Research Institute Release: Pharma Compliance With OIG Guidelines For Executive Marketing & Management Forum To Be Attended By 400-600 Delegates On April 4-5 In New Brunswick, NJ

NEW BRUNSWICK, N.J., Jan. 4 /PRNewswire/ -- New initiatives with increased scrutiny in meeting compliance guidelines from the Office of the Inspector General, PhRMA and the FDA continue to challenge the industry. Pharmaceutical companies must continue to vigilantly manage and monitor their in-house marketing practices and maintain compliance to the highest standards. In fact, OIG is reshaping the process, systems and design of compliance and marketing in the Pharmaceutical industry, according to Strategic Research Institute.

A seminal meeting of senior level executive speakers from 16 pharmaceutical companies will gather early in the year to discuss amongst themselves the most pressing topics. Presenting companies include: Adolor, AstraZeneca, Bayer Healthcare, Biovail Pharmaceuticals, Boehringer Ingleheim Pharmaceuticals, Eli Lilly, Johnson & Johnson, MedImmune, Pfizer, Abbott Laboratories, Sepracor, Serono, Shire Pharmaceuticals, TAP Pharmaceutical Products, and Wyeth Labs.

Topics Include: Medicare Modernization Act Challenges: Fraud & Abuse Implications in Pharma Marketing & Sales Negotiating and Living Under a Pharma Company CIA Best Practices: Current Issues Facing U.S. Compliance Program CME Compliance Exchange Compliance Monitoring and Auditing: Views from Within a Company and from an External Auditor Developing Tools for Effective Program Implementation

The forum, replete with 5 additional and concurrent conference tracks comprises the “4th Pharmaceutical Marketing & Sales Global Summit (PMS)” an annual extravaganza scheduled to take place April 4-5, 2006.

The other tracks are: Strategic Rx Branding Early Stage & Emerging Pharma Marketing Driving Sales Force Productivity Patient Level Data Patient Compliance & Adherence

Registrants to the Forum are welcome to attend sessions from the other meeting tracks.

The annual conference is expected to draw 400-600 attendees at a minimum from around the industry, and from pharmaceutical companies of all sizes. The information and networking gathering is among the largest in the country. Frequent networking sessions for all attendees, speakers, sponsors, and exhibitors are coordinated to bring everyone together. Themed nightly functions are also offered to encourage and facilitate attendee socialization.

Contact Mark Alexay, the event organizer, to request the agenda.

Final speaking and panel slots are still available and proposals may be submitted through Thursday, January 5. Submissions should be titled, 50-100 words and sent to Mark Alexay, Executive Vice President, Life Sciences, Strategic Research Institute and event organizer at or 212.967.0095, extension 251. All industry stakeholders, especially from pharmaceutical companies, are encouraged to submit proposals. Sponsorship and exhibit opportunities with speaking opportunities are still available until January 5. Contact Mark Alexay at

Strategic Research Institute

CONTACT: Mark Alexay, Executive Vice President, Life Sciences, StrategicResearch Institute,, +1-212-967-0095, ext. 251